This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taylor, H. A. Articles by Bovill, E. C. Search for Related Content PubMed PubMed Citation Articles by Taylor, H. A. Articles by Bovill, E. C.

Circulation, Vol 88, 1484-1494, Copyright © 1993 by American Heart Association

ARTICLES

Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

HA Taylor, BR Chaitman, WJ Rogers, MJ Kern, ML Terrin, FV Aguirre, G Sopko, R McMahon, RN Ross and EC Bovill
Division of Cardiovascular Disease, University of Alabama at Birmingham 35294-0007.

BACKGROUND. To better understand the role of race/ethnicity in survival after acute myocardial infarction, we compared clinical and laboratory data, response to thrombolytic therapy, and clinical outcome in 2885 patients participating in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Trial among three groups of patients (2564 whites, 174 blacks, and 147 Hispanics). METHODS AND RESULTS. Differences were found in baseline characteristics among the three groups including (1) age (mean age for whites, 57.2 years; blacks, 54.8 years; Hispanics, 52.8 years; P < .001), (2) sex (percentage of women for whites, 17.6; blacks, 28.7; Hispanics, 14.3; P < .001), and (3) risk factor prevalence: current smoking (percent for whites, 49.4; blacks, 62.1; Hispanics, 55.1; P < .003), history of hypertension (percent for whites, 36.6; blacks, 55.7; Hispanics, 39.5; P < .001), and diabetes mellitus (percent for whites, 11.9; blacks, 22.4; Hispanics, 19.7; P < .001). Changes in hemostatic factors 5 hours after infusion of recombinant tissue plasminogen activator (rt-PA) revealed a more profound fall in fibrinogen levels in black patients compared with the response seen in Hispanic or white patients (mean change in fibrinogen +/- SD, mg/dL: 151.3 +/- 107.4, 112.2 +/- 97.0, 109.4 +/- 98.6; P < .001, respectively) without more frequent infarct-related artery patency or hemorrhagic complications. Mortality was similar in the white, black, and Hispanic patients through the first year after adjustment for baseline variables. CONCLUSIONS. TIMI II data yield evidence that (1) corroborates published reports of a high prevalence of classic cardiovascular risk factors among minority patients with acute myocardial infarction, (2) there is a greater decrease in fibrinogen levels 5 hours after the start of rt-PA infusion among black patients than in white and Hispanic patients without evidence of more frequent infarct-related artery patency or hemorrhagic complications, and (3) thrombolytic therapy with appropriate supplemental measures is associated with comparable 1-year mortality in white, black, and Hispanic patients.

This article has been cited by other articles:

				H. A. Taylor, G. D. Hughes, and R. J. Garrison Cardiovascular Disease Among Women Residing in Rural America: Epidemiology, Explanations, and Challenges Am J Public Health, April 1, 2002; 92(4): 548 - 551. [Abstract] [Full Text]

				M. G. Cohen, C. B. Granger, E. M. Ohman, A. L. Stebbins, L. R. Grinfeld, A. M. Cagide, M. V. Elizari, A. Betriu, D. F. Kong, E. J. Topol, et al. Outcome of hispanic patients treated with thrombolytic therapy for acute myocardial infarction: Results from the GUSTO-I and -III trials J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1729 - 1737. [Abstract] [Full Text] [PDF]

				P. H. Stone, B. Thompson, H. V. Anderson, M. W. Kronenberg, R. S. Gibson, W. J. Rogers, D. J. Diver, P. Theroux, J. W. Warnica, J. B. Nasmith, et al. Influence of Race, Sex, and Age on Management of Unstable Angina and Non--Q-Wave Myocardial Infarction: The TIMI III Registry JAMA, April 10, 1996; 275(14): 1104 - 1112. [Abstract] [PDF]